View Cart (0 items)

Pharmaceutical

J&J Cut CEO''s Pay Nine Percent Amid 2010 Recalls

According to the Associated Press, health care giant Johnson & Johnson lowered Chief Executive William Weldon''s total compensation by 9 percent in 2010, after two years of revenue declines and
Read More

Eli Lilly Plans to Buy Animal Health Business

According to the Associated Press, Eli Lilly and Co. plans to buy the animal health business of Janssen Pharmaceutical NV in a deal that would give Lilly''s Elanco division about
Read More

U.S. Regulators and Johnson & Johnson Unit Reach Plant Oversight Deal

According to The New York Times, federal regulators reached an agreement with a unit of Johnson & Johnson that would impose greater federal oversight at three manufacturing plants responsible for
Read More

FDA Approves First New Drug for Lupus in 56 Years

According to the Associated Press, the Food and Drug Administration approved the first new drug to treat lupus in over 50 years, a milestone that medical experts say could prompt
Read More

Senate Bill Aims to Combat Pharmaceutical Theft

Law enforcement officials would have more leeway to pursue and punish criminals who steal prescription pharmaceuticals under a proposal introduced by Senate lawmakers, according to the Associated Press. A bill
Read More

Japan Halts Pfizer, Sanofi-Aventis Vaccines after Deaths of Four Children

The Associated Press reports that Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who
Read More

J&J Recalls Surgical Sutures Due to Risk of Contamination

Johnson & Johnson has recalled several lots of surgical sutures in the United Kingdom because of a risk they are unsterile, according to the Associated Press. The recall began in
Read More

Pfizer Completes Buyout of King Pharmaceuticals

Pfizer Inc., the world''s largest drugmaker, has completed its acquisition of King Pharmaceuticals Inc. for $3.6 billion, according to the Associated Press. In January, Pfizer completed the tender offer for
Read More

Mylan Gets FDA Approval for Generic Neurontin

Mylan Inc. said its Matrix Laboratories unit received Food and Drug Administration approval to market a generic version of Pfizer Inc.''s drug Neurontin, according to the Associated Press. Neurontin was
Read More

Abbott Wins Reversal of J&J’s $1.67 Billion Patent Victory

Abbott Laboratories, maker of the arthritis drug Humira, succeeded in a bid to overturn a $1.67 billion patent-infringement verdict won by Johnson & Johnson. Bloomberg reports the 2009 verdict,
Read More